Lexicon Pharmaceuticals
LXRX
#6550
Rank
A$1.26 B
Marketcap
A$2.84
Share price
0.75%
Change (1 day)
69.65%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): A-$0.11

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is A-$0.09820. In 2025 the company made an earnings per share (EPS) of A-$0.20 an increase over its 2024 EPS that were of A-$0.90.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.11-46.52%
2025A-$0.20-78.13%
2024A-$0.90-20%
2023A-$1.1231.15%
2022A-$0.86-0%
2021A-$0.8610.91%
2020A-$0.77-145.08%
2019A$1.71-206.09%
2018A-$1.61-5.74%
2017A-$1.71-10.95%
2016A-$1.922640%
2015A-$0.07014-96.34%
2014A-$1.91-2.53%
2013A-$1.96-9.09%
2012A-$2.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$25.56-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$7.76-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$59.66-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
A-$8.57 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$11.00-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A-$0.02806-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
A-$1.05 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$1.96-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
A-$2,296 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA